Background
Leukocytes, which are responsible for mediating inflammation and immunity, remain inactive and non-adherent while circulating in the blood, but can be rapidly activated and recruited to tissues in response to inflammatory mediators or infection. Integrins of the β2 subfamily are required for leukocyte adhesion to endothelial cells and migration into tissues; they also mediate effector functions, such as the interaction of natural killer (NK) and cytotoxic T cells with their targets, the binding of T cells to antigen-presenting cells and the phagocytosis of complement-opsonized particles [1, 2] . This crucial role of β2 integrins is most clearly demonstrated in patients with leukocyte adhesion deficiency (LAD) syndrome, where mutations in this integrin chain (CD18) dramatically increase susceptibility to bacterial infections [3] . Functional activation of the three major β2-containing integrins, αLβ2 (CD11a/CD18, LFA-1), αMβ2 (CD11b/CD18, CR3), and αXβ2 (CD11c/CD18, p150,95), is induced in several pro-inflammatory conditions, for example after T-cell receptor crosslinking and in response to a variety of inflammatory mediators such as lipopolysaccharide (LPS) and other bacterial products, tumor necrosis factor-α (TNF-α) and platelet-activating factor (PAF) [1, [4] [5] [6] [7] [8] [9] . The signal transduction pathway linking the membrane receptors for these diverse agonists to β2 integrin activation is not clear. As there have been several reports that small GTPases of the Ras family can regulate integrin function in a variety of cell types [10] [11] [12] [13] [14] we have examined their role in the activation of the αMβ2 complement receptor in the macrophage. We show that the Rap1 GTPase specifically regulates functional activation of the αMβ2 integrin in response to a wide variety of inflammatory mediators.
Results and discussion
To determine whether Ras-like small GTPases are involved in activation of the αMβ2 CR3 receptor, we first made use of TcdB-1470, a Clostridium difficile toxin that has been reported to glucosylate and inactivate Rac and also three members of the Ras family -R-ras, RalA and Rap1 [15] . As shown in Figure 1a , TcdB-1470 completely abolished (at least 95% inhibition) the phagocytosis of C3bi-opsonized sheep red blood cells in J774.A1 murine macrophage cells stimulated with the phorbol ester PMA. Inhibition of phagocytosis by TcdB-1470 was concentration-dependent and did not affect cell viability (data not shown). Using flow cytometry, we confirmed that PMA (and TcdB-1470) does not affect the surface expression of αMβ2 ( Figure 1b ).
As we have previously shown that Rac is not involved in CR3-mediated phagocytosis [16] , the toxin result suggests that the three Ras-like GTPases, R-ras, RalA or Rap1 might be involved in PMA-induced αMβ2 activation. To determine whether Ras-like small GTPases can activate αMβ2, expression constructs encoding constitutively activated versions of R-ras (V38), RalA (L72), Rap1 (V12) and Ras (V12) were microinjected into macrophage cells and phagocytosis of C3bi-opsonized particles determined. Figure 2a shows that expression of either R-Ras (V38) or Rap1 (V12) was sufficient to trigger efficient CR3-mediated phagocytosis. Both the phagocytic index and the percentage of cells able to phagocytose C3bi-opsonized RBC increased dramatically upon macrophage activation or expression of active R-Ras or Rap1 (control, 9 ± 4%; PMAactivated cells, 69 ± 10%; R-Ras(V38)-expressing cells, 67 ± 4%; Rap1(V12)-expressing cells, 68 ± 11%; n = 3). Control cells never show more than one internalized particle per cell, whereas >50% of R-ras, Rap1-expressing and PMA-activated cells show between two and seven phagocytosed particles per cell. By contrast, RalA (L72) or Ras (V12) did not induce β2-dependent phagocytosis (Figure 2b) . We conclude that when overexpressed, two members of the Ras family, R-Ras and Rap1, can induce functional activation of the αMβ2 integrin in macrophages.
To identify which of these GTPases actually mediates integrin activation in macrophages, we first microinjected J774.A1 cells with expression constructs encoding dominant-negative versions of R-ras and Rap1 and then activated the cells with PMA. As shown in Figure 2c , dominant-negative Rap1 (N17) completely inhibited phagocytosis to below control levels, whereas dominant negative R-Ras (N43), Rac (N17) and RalA (N28) had no effect on CR3-mediated phagocytosis of C3bi-opsonized targets. To confirm the specificity of the dominant-negative Rap1, a construct encoding a Rap-specific GTPaseactivating protein, Rap1GAP [17] , was microinjected into macrophages and this also completely inhibited PMAinduced activation of αMβ2 and phagocytosis (Figure 2c ).
In a further control, we have shown that expression of Rap1 (N17) does not affect the ability of J774 cells to phagocytose IgG-opsonized targets (data not shown), a process known to be independent of macrophage activation [18] . Ras has been reported to downregulate integrin function in some cell types [13, 19] . To determine whether Ras exerts a tonic inhibitory effect on αMβ2 in macrophages, we injected a dominant-negative Ras (N17) construct. This did not lead to activation of CR3 function nor did it inhibit PMA-induced activation ( Figure 2c ).
To determine whether Rap1 regulates the ability of αMβ2 to interact with complement-opsonized targets, or the ability of αMβ2 integrin to internalize bound particles, we measured the effect of modifying Rap1 on particle binding. Figure 2d shows that expression of active Rap1 or R-Ras induces a two-to threefold increase in the number of C3bi-opsonized RBC bound by macrophages. In non-activated J774 cells, inhibition of Rap1, either through expression of the dominant-negative Rap1 or after treatment with TcdB-1470, reduced binding to around one particle per cell. An anti-CR3 antibody (M1/70), that is known to block C3bi binding [2] and that inhibits by ≥95% the number of C3bi-opsonized particles that bind to CR3-transfected COS cells [16] , also reduces the number of bound particles to one per cell. We conclude therefore that inhibition of Rap1 in J774 macrophage cells essentially eliminates binding of C3bi-opsonized red blood cells to the αMβ2 complement receptor. TcdB-10463, another C. difficile toxin that inhibits Rho, Rac and Cdc42 [20] and has previously been shown to inhibit CR3-mediated phagocytosis [16] , did not affect binding of C3bi-opsonized RBC to macrophages (data not shown). Neither Rap1 (N17) nor TcdB-1470 affected the ability of J774 cells to bind IgG-opsonized targets (data not shown).
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Finally, to confirm that each of these agonists is capable of activating endogenous Rap1, we have carried out pulldown assays using a RalGDS-GST fusion protein, to determine the levels of GTP-bound Rap1 in cells (Figure 3c ). Whereas control cells do contain detectable levels of GTP-bound Rap1, all three inflammatory mediators induced a significant increase in Rap1 GTP levels ( Figure 3c , and data not shown), which preceded the acquisition of phagocytic potential.
Conclusions
In conclusion, we have identified three distinct receptors for inflammatory mediators that induce functional activation of the macrophage integrin, αMβ2, through a Rap1-controlled signal transduction pathway. LPS and TNF-α interact with the Toll/IL-1 and TNFR family of receptors, respectively, which mediate their intracellular effects through adaptorlike proteins such as Myd88, TRAFs and TRADD, whereas PAF acts on a serpentine, G-protein-coupled receptor [22] [23] [24] . As numerous Rap1-specific exchange factors (GEFs) have been identified, it remains to be seen whether one or more are involved downstream of these diverse families of receptors [25, 26] . The biochemical signals controlled by Rap1 that mediate functional activation of the β2 integrin are unclear, but they appear to be both necessary and sufficient for integrin activation and do not function in these cells by antagonizing Ras [19, 27] . Because Ras does not activate αMβ2, the Rap1 effector that mediates this response must be distinct from the known Ras effectors [28] . Similar conclusions have recently been reported, and Rap1 activity has been shown to control the stimulus-induced adhesion, dependent on the cell adhesion molecule LFA-1, of stably transfected cells to surfaces coated with the cell adhesion molecule ICAM-1, without affecting β2 surface expression [29, 30] . Furthermore, we show that Rap1 acts upstream of the αMβ2 integrin to regulate its ability to bind C3bi-opsonized particles. It is generally thought that three mechanisms can contribute to integrin activation: a change in integrin affinity, by altering its conformation; an increase in avidity through integrin clustering; or a change in the interaction of αMβ2 with the cytoskeleton [31] . There are conflicting reports about the mechanism(s) underlying agonist-induced activation of αMβ2, and exposure of activation-specific epitopes and a role for the actin cytoskeleton have both been proposed [32, 33] .
We previously showed that Rho acts downstream of CR3 to mediate phagocytosis in macrophages [16] and we show here that Rap1 acts upstream of CR3 to regulate its activity. This nicely demonstrates the cooperation between two distinct small GTPases to promote a coordinated biological response. Finally, it remains to be seen whether Rap1 controls integrin activation in general; in this respect, it is worth noting that Rap1 was first identified as Krev-1, a gene able to induce flat revertants in Ras-transformed cells [27] . Nevertheless, in view of its role in controlling β2-integrin activation, both in macrophages, as shown here, and in T cells [29, 30] , we would expect Rap1 to have a key role in inflammation and immunity in vivo.
Materials and methods
R-Ras (V38), Rac (V12) and Rac (N17) [34, 35] were subcloned into the mammalian expression vector pRK5myc. Point mutations were introduced by site-directed mutagenesis into wild-type constructs to generate H-Ras (V12), H-Ras (N17), Rap1 (V12), Rap1 (N17), RalA (L72) and R-Ras (N43), which were then subcloned into pRK5myc. pMT2-HARapGAP and pMT2-HA-RalA (N28) were provided by Johannes Bos (University of Utrecht, the Netherlands). Purified B toxins, isolated from strains 1470 or 10463 of C. difficile (herein referred to as TcdB-1470 and TcdB-10463, respectively), were kind gifts of C. von Eichel-Streiber (Johannes Gutenberg University, Mainz, Germany).
J774.A1 macrophage-like cells (American Type Culture Collection) were grown in DMEM supplemented with 10% heat-inactivated FCS (Sigma). They were treated with bacterial toxins for 2 h at 37°C in serum-free medium (SFM) containing 10 mM HEPES. Cell activation with PMA (Sigma), used at 150 pg/ml for 15 min, recombinant human TNF-α (R&D Systems), used at 50 ng/ml for 30 min, or PAF (Calbiochem), used at 5 nM for 15 min was also performed in HEPES-supplemented SFM. By constrast, LPS (from Escherichia coli 055:B5; Sigma) was used at 100 ng/ml for 30 min in DMEM supplemented with 10% heat-inactivated FCS. In all cases, cells were quickly washed in SFM before being used in subsequent assays.
For the analysis of αM surface expression, J774.A1 cells were treated with various agonists or toxins as indicated above, then washed and scraped in cold PBS supplemented with 0.5% BSA, 0.02% azide and excess IgG, and subsequently stained using a rat monoclonal antibody (M1/70, Pharmingen) and FITC-coupled anti-rat IgG (Jackson ImmunoResearch Laboratories). Samples were run on a FACSCalibur (Becton Dickinson) according to the manufacturer's instructions and data were analyzed using the CellQuest software.
Microinjection of J774.A1 cells, the preparation of C3bi-opsonized red blood cells, the phagocytic assay and the staining procedures have been described before [16] . Briefly, cells were transferred to HEPEScontaining SFM immediately before injection. The tagged DNA constructs (0.1 mg/ml) were microinjected along with lysine-fixable 10,000 MW biotin dextran (Molecular Probes), at a final concentration of 2.5 mg/ml, into the nucleus of at least 50 cells. Cells were returned to the incubator for 2.5 h, to allow expression of the corresponding proteins, before the phagocytic assay. In some experiments, cells were activated with PMA or inflammatory molecules before the phagocytic Research Paper Rap1 controls α αMβ β2 integrin activation Caron, Self and Hall 977 challenge. C3bi-opsonized red blood cells, resuspended in HEPESbuffered SFM, were fed to macrophages for 30 min (target-to-cell ratio = 20) at 37°C. Cells were fixed in 4% paraformaldehyde for 20 min at 4°C and processed for immunofluorescence. Injected cells were visualized using AMCA-coupled streptavidin (Molecular Probes). Phagocytosis was, however, assessed only in the Myc-or haemagglutinin (HA)-positive cells, visualized after immunofluorescent staining using the 9E10 anti-Myc or the 3F10 anti-HA (Boehringer Mannheim) monoclonal antibodies. Phagocytic index is defined as the number of red blood cells internalized per 100 macrophages.
Rap1 pull-downs were conducted essentially as described [36] using 20 µg GST-RalGDS-RBD and 2 × 10 7 J774.A1 cells per point. Cells were kept in HEPES-supplemented SFM, or stimulated as indicated with PMA (150 ng/ml), PAF (5 nM), serum-supplemented medium or LPS (100 ng/ml) in serum-containing medium. Samples were run on 15% acrylamide SDS-PAGE gels, blotted and probed with a monoclonal anti-Rap1 antibody (Transduction Laboratories) followed by a horseradish peroxidase-conjugated anti-mouse serum (Pierce) and revealed by chemiluminescence (ECL kit, Amersham).
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